AstraZeneca chief Pascal Soriot has said a deepening criminal probe into his company’s Chinese business is being taken “very ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy ... With this chart, I'd like to take a moment to address recent developments in China, which, of course, have been ...

“If requested we will fully cooperate with the authorities.” AstraZeneca last week said its China head, Leon Wang, was ...

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Qu – which according to Parsa is the fruit of a collaboration between a global team of experienced AI scientists, ...

“We have to accept that not everyone can be famous for tech and life sciences,” said one person at the meeting, which ...

IonQ, the Maryland-based developer of quantum computing systems that recently signed a $55 million deal with the US Air Force ...

By signing up with an email address, I acknowledge that I have read and agree to ... Some of our programs are wholly owned, ...

Subscribe here to receive future editions. AstraZeneca said it is doubling down on its investment in its U.S. business, a ...

AstraZeneca (AZN) said it plans to spend $3.5B to expanding its research and manufacturing capabilities in the United States ...